Pierre Dominique Delmas
#110,766
Most Influential Person Across History
Pierre Dominique Delmas's AcademicInfluence.com Rankings
Pierre Dominique Delmasmedical Degrees
Medical
#960
Historical Rank
Public Health
#75
Historical Rank
Epidemiology
#95
Historical Rank
Download Badge
Medical Biology
Pierre Dominique Delmas's Degrees
- PhD Nutritional Sciences Université Paris Cité
Why Is Pierre Dominique Delmas Influential?
(Suggest an Edit or Addition)Pierre Dominique Delmas's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Vitamin D3 and calcium to prevent hip fractures in elderly women. (1992) (2875)
- Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. (1999) (2724)
- Denosumab for prevention of fractures in postmenopausal women with osteoporosis. (2009) (2299)
- Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. (2007) (2189)
- Bone quality--the material and structural basis of bone strength and fragility. (2006) (1886)
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008) (1750)
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. (1994) (1459)
- Body mass index as a predictor of fracture risk: A meta-analysis (2005) (1439)
- Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. (1997) (1357)
- Predictive Value of BMD for Hip and Other Fractures (2005) (1308)
- A meta-analysis of previous fracture and subsequent fracture risk. (2004) (1162)
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis (2004) (1158)
- Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-year Randomized Clinical Trial (2000) (1148)
- In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. (2005) (1137)
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (1998) (1129)
- Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study (1996) (996)
- Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis (1996) (992)
- The role of collagen in bone strength (2005) (911)
- Dietary supplementation in elderly patients with fractured neck of the femur (1990) (822)
- Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis (1999) (739)
- Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. (1994) (737)
- Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study (2000) (702)
- The Use of Biochemical Markers of Bone Turnover in Osteoporosis (2000) (688)
- SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS (1984) (673)
- Exercise Before Puberty May Confer Residual Benefits in Bone Density in Adulthood: Studies in Active Prepubertal and Retired Female Gymnasts (1998) (647)
- Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. (2000) (602)
- The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases* (1998) (602)
- Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters. (1990) (589)
- Guidelines for diagnosis and management of osteoporosis (2005) (557)
- Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. (2002) (543)
- Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. (2001) (525)
- Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. (2003) (512)
- Incorporation and distribution of strontium in bone. (2001) (508)
- Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. (1993) (494)
- Underdiagnosis of Vertebral Fractures Is a Worldwide Problem: The IMPACT Study (2004) (487)
- Treatment of postmenopausal osteoporosis (2002) (454)
- Finite Element Analysis Based on In Vivo HR‐pQCT Images of the Distal Radius Is Associated With Wrist Fracture in Postmenopausal Women (2007) (445)
- Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. (1990) (433)
- Alterations of Cortical and Trabecular Architecture Are Associated With Fractures in Postmenopausal Women, Partially Independent of Decreased BMD Measured by DXA: The OFELY Study (2007) (428)
- Biochemical markers of bone turnover (1993) (416)
- The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. (1988) (394)
- Change in Bone Turnover and Hip, Non‐Spine, and Vertebral Fracture in Alendronate‐Treated Women: The Fracture Intervention Trial (2004) (387)
- The effects of tibolone in older postmenopausal women. (2008) (386)
- Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. (1998) (385)
- Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. (1993) (384)
- Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage (2001) (382)
- EFFECTS OF RALOXIFENE ON BONE MINERAL DENSITY, SERUM CHOLESTEROL CONCENTRATIONS, AND UTERINE ENDOMETRIUM IN POSTMENOPAUSAL WOMEN (1998) (373)
- Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study (2005) (373)
- Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. (1991) (370)
- Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. (1995) (368)
- Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. (1997) (368)
- Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. (1996) (359)
- Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. (1998) (358)
- Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. (1983) (350)
- A New Approach to the Development of Assessment Guidelines for Osteoporosis (2002) (335)
- Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study. (2003) (325)
- Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study (2005) (323)
- Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1‐Year Results From the MOBILE Study (2005) (323)
- Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial. (2002) (323)
- Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. (2000) (316)
- Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis (1991) (313)
- Reviews and Notes: Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis (1995) (312)
- Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. (2002) (307)
- Biological markers in osteoarthritis (2007) (304)
- Apparent Pre‐ and Postmenopausal Bone Loss Evaluated by DXA at Different Skeletal Sites in Women: The OFELY Cohort (1997) (300)
- Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. (2004) (296)
- MANAGEMENT OF PAGET’S DISEASE OF BONE (1997) (294)
- Low Skeletal Muscle Mass Is Associated With Poor Structural Parameters of Bone and Impaired Balance in Elderly Men—The MINOS Study (2004) (281)
- Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women (1994) (281)
- Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. (2001) (279)
- Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study. (1997) (278)
- Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study (2004) (277)
- Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. (1988) (276)
- Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. (1996) (271)
- Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate (2010) (259)
- Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. (2006) (258)
- Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. (2001) (258)
- Markers of Bone Turnover Predict Postmenopausal Forearm Bone Loss Over 4 Years: The OFELY Study (1999) (254)
- Long-term effects of intravenous pamidronate in fibrous dysplasia of bone (1994) (252)
- Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. (1997) (249)
- Glutamate receptors are expressed by bone cells and are involved in bone resorption. (1998) (249)
- Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. (1999) (243)
- Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro (1994) (233)
- Incidence of Limb Fracture across Europe: Results from the European Prospective Osteoporosis Study (EPOS) (2002) (233)
- Mortality Associated with Vertebral Deformity in Men and Women: Results from the European Prospective Osteoporosis Study (EPOS) (1998) (229)
- Effects of Bazedoxifene on BMD and Bone Turnover in Postmenopausal Women: 2‐Yr Results of a Randomized, Double‐Blind, Placebo‐, and Active‐Controlled Study (2007) (227)
- Six and Twelve Month Changes in Bone Turnover are Related to Reduction in Vertebral Fracture Risk During 3 Years of Raloxifene Treatment in Postmenopausal Osteoporosis (2001) (227)
- Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. (2009) (226)
- Markers of bone turnover for the management of patients with bone metastases from prostate cancer (2000) (225)
- Different effects of bisphosphonate and estrogen therapy on free and peptide‐bound bone cross‐links excretion (1995) (222)
- Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. (1998) (218)
- Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. (2008) (218)
- Bone Fragility: Failure of Periosteal Apposition to Compensate for Increased Endocortical Resorption in Postmenopausal Women (2006) (218)
- Effect of renal function on plasma levels of bone Gla-protein. (1983) (217)
- Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure (2007) (214)
- Mineral maturity and crystallinity index are distinct characteristics of bone mineral (2010) (214)
- Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture (1993) (212)
- Relationship Between Changes in Biochemical Markers of Bone Turnover and BMD to Predict Vertebral Fracture Risk (2003) (210)
- Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis (2008) (206)
- Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. (2006) (205)
- Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. (1983) (204)
- The short-term effects of conjugated estrogen on bone turnover in older women. (1994) (203)
- Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women (1995) (203)
- Histomorphometric and μCT Analysis of Bone Biopsies From Postmenopausal Osteoporotic Women Treated With Strontium Ranelate (2007) (199)
- Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. (2000) (197)
- Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women (2000) (197)
- Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. (2004) (196)
- Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. (2008) (195)
- Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. (1994) (195)
- Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells (1994) (195)
- Diagnosis and management of osteoporosis in postmenopausal women: Clinical guidelines (1999) (195)
- Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. (2008) (191)
- Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. (2001) (191)
- Bone loss after orthotopic liver transplantation. (1994) (191)
- Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. (2010) (189)
- The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients. (2008) (188)
- Biochemical Indices of Bone Turnover and the Assessment of Fracture Probability (2002) (187)
- Contribution of Trochanteric Soft Tissues to Fall Force Estimates, the Factor of Risk, and Prediction of Hip Fracture Risk* (2007) (184)
- Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study (2006) (183)
- Prevalent Vertebral Deformity Predicts Incident Hip though not distal Forearm Fracture: Results from the European Prospective Osteoporosis Study (2001) (182)
- Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. (2004) (182)
- Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases. (1985) (182)
- Non-enzymatic Glycation of Bone Collagen Modifies Osteoclastic Activity and Differentiation* (2007) (182)
- Safety and Efficacy of Risedronate in Reducing Fracture Risk in Osteoporotic Women Aged 80 and Older: Implications for the Use of Antiresorptive Agents in the Old and Oldest Old (2004) (181)
- Recognizing and reporting osteoporotic vertebral fractures (2003) (180)
- Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. (2007) (179)
- Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. (2007) (178)
- Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women (1988) (177)
- Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial (2005) (173)
- The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? (1995) (173)
- Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. (2006) (173)
- Biochemical Markers of Bone Turnover and Prediction of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures (1999) (172)
- Once‐Weekly Risedronate in Men With Osteoporosis: Results of a 2‐Year, Placebo‐Controlled, Double‐Blind, Multicenter Study (2009) (172)
- Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study (1996) (170)
- Clinical use of biochemical markers of bone remodeling in osteoporosis. (1992) (169)
- Finite element analysis performed on radius and tibia HR-pQCT images and fragility fractures at all sites in postmenopausal women. (2010) (165)
- Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. (1990) (165)
- Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis. (2004) (165)
- Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. (1993) (165)
- Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. (2008) (162)
- Change in Lumbar Spine BMD and Vertebral Fracture Risk Reduction in Teriparatide‐Treated Postmenopausal Women With Osteoporosis (2006) (162)
- Long‐Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of Bone (1997) (158)
- Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma. (2002) (157)
- Lasofoxifene in postmenopausal women with osteoporosis. (2010) (156)
- Skeletal distribution and biochemical parameters of Paget's disease. (1987) (155)
- Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. (2000) (154)
- Microcrack Frequency and Bone Remodeling in Postmenopausal Osteoporotic Women on Long‐Term Bisphosphonates: A Bone Biopsy Study (2007) (153)
- Immunoassay of pyridinoline crosslink excretion in normal adults and in paget's disease (1993) (152)
- Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. (2004) (151)
- Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States (2009) (149)
- Increased bone resorption in moderate smokers with low body weight: the Minos study. (2002) (148)
- Markers of bone turnover in hyperthyroidism and the effects of treatment. (1994) (148)
- Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. (2004) (146)
- Potential mediators of the mortality reduction with zoledronic acid after hip fracture (2010) (146)
- Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. (2000) (146)
- Bone gla protein (osteocalcin) assay standardization report (1990) (145)
- Lack of Correlation Between Start Codon Polymorphism of the Vitamin D Receptor Gene and Bone Mineral Density in Premenopausal French Women: The OFELY Study (1998) (143)
- Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures. (1990) (143)
- Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial. (2008) (142)
- Genetic influence on bone turnover in postmenopausal twins. (1996) (142)
- Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry. (1986) (139)
- Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra (2008) (138)
- Biochemical markers of bone turnover. Applications for osteoporosis. (1998) (138)
- Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia. (1992) (134)
- Cross-sectional assessment of age-related bone loss in men: the MINOS study. (2000) (134)
- The impact of osteoporosis on quality-of-life: the OFELY cohort. (2002) (134)
- Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases (2007) (134)
- Biochemical markers of bone turnover in osteoporosis. (1997) (133)
- Collagen Iα1 Sp1 Polymorphism, Bone Mass, and Bone Turnover in Healthy French Premenopausal Women: The OFELY Study (1998) (133)
- Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. (2003) (132)
- Finite element analysis performed on radius and tibia HR‐pQCT images and fragility fractures at all sites in men (2011) (131)
- Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. (1992) (130)
- Severity of Vertebral Fractures Is Associated With Alterations of Cortical Architecture in Postmenopausal Women (2009) (130)
- Longitudinal Study of Bone Loss in Pre- and Perimenopausal Women: Evidence for Bone Loss in Perimenopausal Women (2000) (129)
- Adherence to treatment of osteoporosis: a need for study (2007) (128)
- Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma. (1982) (126)
- Monitoring individual response to hormone replacement therapy with bone markers. (2000) (126)
- Type I Collagen Racemization and Isomerization and the Risk of Fracture in Postmenopausal Women: The OFELY Prospective Study (2002) (125)
- Structural determinants of hip fracture in elderly women: re-analysis of the data from the EPIDOS study (2006) (124)
- Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. (2002) (123)
- Markers of Bone Turnover for Monitoring Treatment of Osteoporosis with Antiresorptive Drugs (2000) (122)
- Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis (2003) (121)
- Cross‐Sectional Evaluation of Bone Metabolism in Men * (2001) (121)
- Anti-vertebral fracture efficacy of raloxifene: a meta-analysis (2006) (116)
- Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data (2009) (115)
- Decreased bone turnover in oral contraceptive users. (1995) (114)
- Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis (2009) (113)
- Circulating levels of vitamin K1 and K2 are decreased in elderly women with hip fracture (1992) (112)
- Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. (1994) (111)
- Biochemical markers of bone turnover. I: Theoretical considerations and clinical use in osteoporosis. (1993) (111)
- Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates. (2007) (111)
- Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. (1995) (111)
- Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause mortality in older men: the prospective MINOS study. (2010) (110)
- Contribution of Trabecular and Cortical Components to Biomechanical Behavior of Human Vertebrae: An Ex Vivo Study (2010) (109)
- Time sequence of secondary mineralization and microhardness in cortical and cancellous bone from ewes. (2010) (108)
- Long term effects of dichloromethylene diphosphonate in Paget's disease of bone. (1982) (108)
- Dual Energy X-Ray Absorptiometry Measurement of Bone Mineral Content in Newborns: Validation of the Technique (1992) (107)
- The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort (2010) (106)
- Serum bone GLA‐protein in growth hormone deficient children (1986) (106)
- Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases. (2008) (104)
- How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? (2000) (103)
- Bone mineral density predicts osteoporotic fractures in elderly men: the MINOS study (2005) (102)
- Decreased β‐Isomerization of the C‐Terminal Telopeptide of Type I Collagen α1 Chain in Paget's Disease of Bone (1997) (101)
- Efficacy and safety of ibandronate given by intravenous injection once every 3 months. (2004) (100)
- Calcifications in the Abdominal Aorta Predict Fractures in Men: MINOS Study (2007) (100)
- Assessment of hand bone loss in rheumatoid arthritis by high-resolution peripheral quantitative CT (2010) (100)
- The use of bisphosphonates in the treatment of osteoporosis (2005) (100)
- Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover. (2006) (99)
- Serum Estradiol and Sex Hormone‐Binding Globulin and the Risk of Hip Fracture in Elderly Women: The EPIDOS Study (2000) (97)
- Men with metabolic syndrome have lower bone mineral density but lower fracture risk—the MINOS study (2010) (97)
- Early impairment of trabecular microarchitecture assessed with HR‐pQCT in patients with stage II‐IV chronic kidney disease (2009) (97)
- Cross‐sectional analysis of the association between fragility fractures and bone microarchitecture in older men: The STRAMBO study (2011) (96)
- Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. (2004) (95)
- Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover. (2000) (95)
- Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain (1999) (95)
- Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone (1999) (94)
- Role of Trabecular Microarchitecture and Its Heterogeneity Parameters in the Mechanical Behavior of Ex Vivo Human L3 Vertebrae (2010) (92)
- Complex formation of human thrombospondin with osteonectin. (1988) (91)
- Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. (2009) (91)
- Drug Insight: bisphosphonates for postmenopausal osteoporosis (2006) (91)
- Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up) (1997) (91)
- Abnormal serum bone gla protein levels in multiple myeloma: Crucial role of bone formation and prognostic implications (1990) (90)
- Effects of a New Selective Estrogen Receptor Modulator (MDL 103,323) on Cancellous and Cortical Bone in Ovariectomized Ewes: A Biochemical, Histomorphometric, and Densitometric Study (2001) (89)
- Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. (1999) (88)
- The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design (2009) (88)
- Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products. (1999) (87)
- Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation (2004) (87)
- Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. (1994) (87)
- Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). (2011) (86)
- Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study. (2004) (85)
- Cortical and trabecular bone distribution in the femoral neck in osteoporosis and osteoarthritis. (2008) (85)
- Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system (2008) (85)
- Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral density. (2005) (85)
- Biomarkers in osteoarthritis (2003) (84)
- Biochemical markers of bone turnover: methodology and clinical use in osteoporosis. (1991) (83)
- High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study (2007) (83)
- Influence of experimental conditions on osteoblast activity in human primary bone cell cultures (1990) (83)
- Effectiveness of instant vertebral assessment to detect prevalent vertebral fracture (2006) (82)
- Markers of bone turnover in bone metastases (2000) (82)
- Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry. (1986) (82)
- Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men (2005) (81)
- Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW) (2010) (81)
- Rate of Forearm Bone Loss Is Associated With an Increased Risk of Fracture Independently of Bone Mass in Postmenopausal Women: The OFELY Study (2005) (81)
- A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover. (1999) (80)
- Microarchitecture Influences Microdamage Accumulation in Human Vertebral Trabecular Bone (2008) (80)
- Strong bones in later life: luxury or necessity? (1999) (80)
- Variation in vertebral height ratios in population studies (1994) (80)
- Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: A biochemical and histomorphometric study (1993) (79)
- Serum bone Gla protein: a marker of bone turnover in hyperthyroidism. (1986) (79)
- Bone microdamage: a clinical perspective (2009) (79)
- Bone sialoprotein stimulates in vitro bone resorption. (1996) (78)
- Reconstructing the skeleton with intermittent parathyroid hormone (2001) (78)
- Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. (1987) (77)
- Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. (1998) (76)
- Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate: Review of Statistical Analysis (2007) (76)
- In vitro evaluation of dose-effects of ethanol on human osteoblastic cells. (1993) (75)
- Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis (2010) (74)
- Effects of preexisting microdamage, collagen cross‐links, degree of mineralization, age, and architecture on compressive mechanical properties of elderly human vertebral trabecular bone (2011) (73)
- Biochemical Markers of Bone Turnover in Men (2001) (73)
- Molecular identification of NMDA glutamate receptors expressed in bone cells (2001) (73)
- Serum concentrations of 17β‐E2 and 25‐hydroxycholecalciferol (25OHD) in relation to all‐cause mortality in older men – the MINOS study (2009) (72)
- Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women. (1999) (71)
- The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone. (2001) (70)
- Long‐Term Variability of Markers of Bone Turnover in Postmenopausal Women and Implications for Their Clinical Use: The OFELY Study (2003) (69)
- Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis (2004) (69)
- Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal women (1990) (69)
- Serum bone gla‐protein in multiple myeloma (1987) (68)
- Biochemical assessment of bone turnover and bone fragility in men (2007) (68)
- Bone loss in elderly men: increased endosteal bone loss and stable periosteal apposition. The prospective MINOS study (2007) (68)
- Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resorption. (2000) (67)
- Matrix Delivery Transdermal 17β-Estradiol for the Prevention of Bone Loss in Postmenopausal Women (1999) (66)
- Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application (2008) (66)
- Dramatic decrease of innervation density in bone after ovariectomy. (2005) (65)
- Association between bone turnover rate and bone microarchitecture in men: The STRAMBO study (2010) (64)
- Non-steroidal anti-inflammatory drugs and renal function. (1995) (63)
- The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry (2005) (63)
- Serum osteocalcin increases during fracture healing in elderly women with hip fracture. (1995) (63)
- Do We Need to Change the WHO Definition of Osteoporosis? (2000) (62)
- Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy. (1997) (61)
- Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective (2008) (61)
- Insulin-Like Growth Factor I Is a Determinant of Hip Bone Mineral Density in Men Less Than 60 years of Age: MINOS Study (2004) (61)
- Active NMDA glutamate receptors are expressed by mammalian osteoclasts (1999) (60)
- Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis. (2008) (60)
- Dose effects on ewe bone remodeling of short-term sodium fluoride administration--a histomorphometric and biochemical study. (1991) (60)
- Assessment of vertebral fracture using densitometric morphometry. (2005) (60)
- Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation. (2001) (60)
- Low width of tubular bones is associated with increased risk of fragility fracture in elderly men--the MINOS study. (2006) (59)
- A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal women (1999) (59)
- Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy. (2001) (59)
- Role of sex steroids in the regulation of bone morphology in men. The MINOS study (2004) (59)
- Normal car☐ylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone (1990) (58)
- Disc Space Narrowing Is Associated With an Increased Vertebral Fracture Risk in Postmenopausal Women: The OFELY Study (2004) (57)
- Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the rat (1994) (57)
- MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays. (2007) (57)
- Beyond hip: importance of other nonspinal fractures. (2007) (57)
- New developments in biochemical markers for osteoporosis (2009) (57)
- Mechanisms of the Anabolic Effects of Teriparatide on Bone: Insight From the Treatment of a Patient With Pycnodysostosis (2008) (57)
- Denosumab for prevention of fractures in postmenopausal women with osteoporosis. Editorial comment (2009) (57)
- Increased Bone Resorption Is Associated With Increased Risk of Cardiovascular Events in Men: The MINOS Study (2009) (56)
- Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes. (1992) (56)
- Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women. (2003) (56)
- Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. (2001) (54)
- Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. (2008) (54)
- Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study. (2003) (53)
- Immunological screening of SPARC/Osteonectin in nonmineralized tissues. (1992) (53)
- Platelets contribute to circulating levels of bone sialoprotein in human (1992) (52)
- Bone mass at lumbar spine and tibia in young males--impact of physical fitness, exercise, and anthropometric parameters: a prospective study in a cohort of military recruits. (1995) (52)
- Assessment of the role of 17β‐oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study (2004) (52)
- Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. (1992) (51)
- An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties. (2008) (51)
- Falls explain between-center differences in the incidence of limb fracture across Europe. (2002) (50)
- Biochemical markers of bone turnover for the clinical investigation of osteoporosis (2005) (49)
- Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia—a randomized placebo-controlled trial (2012) (49)
- Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children and children with abnormalities in skeletal development. (1986) (48)
- Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study. (2002) (47)
- Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial (2010) (47)
- Osteopenia and bone‐remodeling abnormalities in warfarin‐treated lambs (1993) (47)
- Comparison of Fracture, Cardiovascular Event, and Breast Cancer Rates at 3 Years in Postmenopausal Women with Osteoporosis (2004) (47)
- Association between collagen cross-links and trabecular microarchitecture properties of human vertebral bone. (2010) (46)
- Biochemical markers of bone turnover. (1995) (45)
- Homocysteine and fracture risk in postmenopausal women: the OFELY study (2007) (45)
- Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women (2008) (45)
- Serum bone-gla protein after fracture. (1990) (45)
- Detection and measurement of vitamins K1 and K2 in human cortical and trabecular bone (1993) (45)
- Impairment of bone turnover in elderly women with hip fracture (1993) (44)
- Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate. (1987) (44)
- Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study. (2003) (43)
- Biochemical markers of bone formation reflect endosteal bone loss in elderly men--MINOS study. (2005) (43)
- Immunochemical studies of conformational alterations in bone gamma-carboxyglutamic acid containing protein. (1984) (42)
- An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis. (2002) (41)
- Simple and sensitive method for quantification of fluorescent enzymatic mature and senescent crosslinks of collagen in bone hydrolysate using single-column high performance liquid chromatography. (2009) (41)
- Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers (2004) (41)
- Serum and synovial fluid osteocalcin (bone gla protein) levels in joint disease. (1989) (40)
- LIF, but Not IL‐6, Regulates Osteoprogenitor Differentiation in Rat Calvaria Cell Cultures: Modulation by Dexamethasone (1998) (40)
- Comparison of 2D and 3D bone microarchitecture evaluation at the femoral neck, among postmenopausal women with hip fracture or hip osteoarthritis. (2011) (40)
- Diabetes during pregnancy does not alter whole body bone mineral content in infants. (1997) (40)
- Selective attachment of osteoprogenitors to laminin. (1999) (40)
- Perinatal serum bone Gla-protein and vitamin D metabolites in preterm and fullterm neonates. (1987) (40)
- Lateral dual-photon absorptiometry: a new technique to measure the bone mineral density at the lumbar spine. (1991) (39)
- A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate (2006) (39)
- Osteoclast spreading kinetics are correlated with an oscillatory activation of a calcium-dependent potassium current (2002) (39)
- Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone. (1990) (39)
- Disc space narrowing as a new risk factor for vertebral fracture: the OFELY study. (2006) (38)
- Radiologic assessment of age-related knee joint space changes in women: a 4-year longitudinal study. (2009) (38)
- Identification of the noncollagenous proteins of bovine bone by two-dimensional gel electrophoresis (1984) (38)
- Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction. (1991) (37)
- Association of bone microarchitecture with parathyroid hormone concentration and calcium intake in men: the STRAMBO study. (2011) (37)
- Can we stop bone loss and prevent hip fractures in the elderly? (2005) (37)
- Predictive value of BMD for hip and other fractures (Journal of Bone and Mineral Research (2005) 20, (1185-1194)) (2007) (37)
- Clinical effects of strontium ranelate in women with postmenopausal osteoporosis (2004) (36)
- Radioimmunoassay for osteonectin. Concentrations in bone, nonmineralized tissues, and blood (1987) (36)
- Bone loss induced by cancer treatment and its management. (1998) (36)
- What do we know about biochemical bone markers? (1991) (35)
- Hormone replacement therapy in the prevention and treatment of osteoporosis (2005) (35)
- Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide. (2004) (35)
- Dual-Energy X-Ray Absorptiometry in Small Subjects: Influence of Dual-Energy X-Ray Equipment on Assessment of Mineralization and Body Composition in Newborn Piglets (1999) (35)
- Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men (2005) (35)
- Adverse effects of a SERM (Levormeloxifene). Safety parameters and bone mineral density 12 months after treatment withdrawal. (2003) (35)
- Investigation of Bone Disease Using Isomerized and Racemized Fragments of Type I Collagen (2002) (35)
- Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density (2010) (34)
- Pachydermoperiostosis with gastric hypertrophy, anemia, and increased serum bone Gla-protein levels. (1988) (34)
- Estimated numbers of postmenopausal women treated by hormone therapy in France. (2005) (34)
- Automatic-interactive measurement of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinoline. (1995) (34)
- Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis. (2002) (34)
- Bisphosphonates in the treatment of bone diseases. (1996) (34)
- Intraocular pressure changes and alterations in intracranial pressure (2000) (33)
- The Use of Placebo-Controlled and Non-inferiority Trials for the Evaluation of New Drugs in the Treatment of Postmenopausal Osteoporosis (2002) (33)
- [Biochemical markers of bone turnover : clinical usefulness in osteoporosis]. (1999) (33)
- Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry. (1987) (32)
- Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1. (1997) (32)
- Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis. (2000) (32)
- The fracture risk index and bone mineral density as predictors of vertebral structural failure (2005) (31)
- The use of different dual X-ray absorptiometry brands in a multicenter clinical trial: consequences and limits. (1999) (31)
- Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane. (1993) (31)
- Dual-energy X-ray absorptiometry in early life. (1997) (31)
- Determinants of the Mechanical Behavior of Human Lumbar Vertebrae After Simulated Mild Fracture (2010) (31)
- A comparative review of the different techniques to assess hand bone damage in rheumatoid arthritis. (2010) (31)
- FRAX® probabilities and risk of major osteoporotic fracture in France (2012) (31)
- Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study. (2009) (30)
- Increases in Hip and Spine Bone Mineral Density are Predictive for Vertebral Antifracture Efficacy with Ibandronate (2010) (30)
- The effects of oral calcitonin on bone collagen maturation: implications for bone turnover and quality (2008) (30)
- Alendronate with and without cholecalciferol for osteoporosis: results of a 15‐week randomized controlled trial* (2006) (30)
- Fluoride exposure and bone status in patients with chronic intestinal failure who are receiving home parenteral nutrition. (2006) (29)
- Osteoporosis and breast cancer. (2004) (29)
- Increased Bone Resorption Is Associated With Higher Mortality in Community‐Dwelling Men ≥50 Years of Age: The MINOS Study (2009) (29)
- Bone marker nomenclature. (2001) (28)
- Osteonectin is an α‐granule component involved with thrombospondin in platelet aggregation (1991) (28)
- A seventy percent overestimation of the burden of hip fractures in women aged 85 and over. (2007) (28)
- Bone imaging and chronic kidney disease: will high-resolution peripheral tomography improve bone evaluation and therapeutic management? (2009) (27)
- Serum osteocalcin (bone Gla-protein), an index of bone growth in lambs. Comparison with age-related histomorphometric changes. (1991) (26)
- 4 Bone markers (1997) (26)
- Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. (2009) (25)
- Bone markers. (1997) (25)
- Effects of moderate physical training on prednisone-induced protein wasting: a study of whole-body and bone protein metabolism. (1988) (25)
- Intertissular variations in osteonectin: A monoclonal antibody directed to bone osteonectin shows reduced affinity for platelet osteonectin (1991) (25)
- Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women (2004) (25)
- Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone. (1997) (24)
- Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis (2008) (24)
- The effect of 2 and 3 years of Raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosis (1998) (24)
- In vitro exposure to sodium fluoride does not modify activity or proliferation of human osteoblastic cells in primary cultures (1993) (24)
- Comparison of bone mass measured by histomorphometry on iliac biopsy and by dual photon absorptiometry of the lumbar spine. (1988) (24)
- Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety. (2006) (23)
- Deterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long‐Term Risk for Fragility Fracture: A Prospective Study (2019) (23)
- Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells. (1993) (23)
- The Proteins of Bone (1993) (22)
- Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science. (2005) (22)
- Indicators of bone formation in weight lifters (1995) (22)
- Specific radioimmunoassay for ovine bone gla-protein (osteocalcin). (1988) (22)
- Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosis. (2003) (22)
- Determinants of Microdamage in Elderly Human Vertebral Trabecular Bone (2013) (21)
- Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women ☆ ☆☆ (2001) (21)
- Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone (2007) (21)
- [Osteocalcin (or bone gla-protein), a new biological marker for studying bone pathology]. (1986) (20)
- Low-Intensity Electrical Stimulation Counteracts the Effects of Ovariectomy on Bone Tissue of Rats: Effects on Bone Microarchitecture, Viability of Osteocytes, and Nitric Oxide Expression (2009) (20)
- Estimated number of women likely to benefit from bone mineral density measurement in France. (2004) (20)
- Patients with rheumatoid arthritis have an altered circulatory aggrecan profile (2008) (20)
- Evidence that free gamma carboxyglutamic acid circulates in serum. (1989) (20)
- Guidelines for diagnosing, prevention and treatment of osteoporosis in Asia (2006) (20)
- Cloning and sequence analysis of bovine bone sialoprotein cDNA: Conservation of acidic domains, tyrosine sulfation consensus repeats, and RGD cell attachment domain (1994) (19)
- Strontium ranelate as a treatment of vertebral osteoporosis (1997) (19)
- Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy (2005) (19)
- A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group. (1999) (18)
- Measurement of serum bone gla-protein (BGP) in humans with an ovine BGP-based radioimmunoassay. (1990) (18)
- Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy (2013) (18)
- Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis (2008) (18)
- Influence of vitamin D and retinoids on the gammacarboxylation of osteocalcin in human osteosarcoma MG63 cells. (1996) (18)
- The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis : 4-year results from the MORE trial (2000) (18)
- Eulerstrut.cavity, a New Histomorphometric Parameter of Connectivity Reflects Bone Strength and Speed of Sound in Trabecular Bone from Human Os Calcis (2007) (17)
- Dual-energy X-ray absorptiometry of the spine in anteroposterior and lateral projections (1994) (17)
- Vertebral Scheuermann’s disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over (2015) (17)
- Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation. (1991) (17)
- Isoform-specific attachment of osteoprogenitors to laminins: mapping to the short arms of laminin-1. (1999) (17)
- Variability and Response of Urinary Resorption Markers to Hormone Replacement Therapy (1999) (16)
- Corticosteroid-induced changes in the responsiveness of human osteoblast-like cells to parathyroid hormone. (1989) (16)
- Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study. (2009) (16)
- Launch of The Bone and Joint Decade 2000–2010 (2000) (15)
- [Measurement of bone density in the wrist using X-ray absorptiometry: comparison with measurements of other sites]. (1994) (15)
- Comparison of morphometric assessment of prevalent vertebral deformities in women using different reference data. (2000) (15)
- Assessment of Bone Microarchitecture in Chronic Kidney Disease: A Comparison of 2D Bone Texture Analysis and High-Resolution Peripheral Quantitative Computed Tomography at the Radius and Tibia (2010) (15)
- Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis (2009) (15)
- Localization of thrombospondin, CD36 and CD51 during prenatal development of the human mammary gland. (1994) (15)
- NICE recommendations for the prevention of osteoporotic fractures in postmenopausal women. (2008) (14)
- Assessment of urinary pyridinoline excretion with a specific enzyme-linked immunosorbent assay in normal adults and in metabolic bone diseases. (1995) (14)
- The use of clodronate in multiple myeloma. (1991) (14)
- Matrix delivery transdermal 17beta-estradiol for the prevention of bone loss in postmenopausal women. The International Study Group. (1999) (14)
- Distribution of thrombospondin and integrin αv in DCIS, invasive ductal and lobular human breast carcinomas (1995) (13)
- A Rapid Procedure for Purifying Large Amounts of Pyridinoline Crosslinks of Bone (1994) (13)
- Bone mineral density of the hip measured with dual-energy X-ray absorptiometry in normal elderly women and in patients with hip fracture (1991) (13)
- [Measurement of bone mineral content by quantitative digital radiography. First results in the lumbar vertebrae]. (1989) (13)
- How Should the Risk of Fracture in Postmenopausal Women be Assessed? (1999) (13)
- A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data (2012) (12)
- Clinical use of selective estrogen receptor modulators (2001) (12)
- INCREASED VERTEBRAL BONE DENSITY IN HEAVY DRINKERS OF MINERAL WATER RICH IN FLUORIDE (1989) (12)
- Clinical use of selective estrogen receptor modulators. (1999) (11)
- Is the predictive power of previous fractures for new spine and non-spine fractures associated with biochemical evidence of altered bone remodelling? The EPOS study. European Prospective Osteoporosis Study. (2002) (11)
- Bone Remodeling: Biochemical Markers or Bone Biopsy? (2005) (11)
- Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route. (2004) (11)
- Results from Two Randomized Controlled Trials Vertebral Fractures in Postmenopausal Women with Osteoporosis. Teriparatide and Raloxifene Reduce the Risk of New Adjacent (2009) (11)
- [Osteoporosis in Klinefelter's syndrome Quantitative bone histological data in 5 cases and relationship with hormonal deficiency (author's transl)]. (1981) (11)
- Prevalence of vertebral deformities according to the diagnostic method. (1998) (11)
- Evaluation of Risk for Osteoporosis Fractures (2002) (10)
- The perspective of the international osteoporosis foundation on the official positions of the international society for clinical densitometry. (2005) (10)
- How to Interpret Surrogate Markers of Efficacy in Osteoporosis (2005) (10)
- [Acceptability and tolerance of prednisolone metasulfobenzoate in orally dispersing tablet]. (2001) (10)
- Risk factors for peripheral fractures vary by age in older men—the prospective MINOS study (2011) (10)
- [Effects of weightlessness on phospho-calcium metabolism and its hormonal regulation in man during the 51 G Franco-American space flight]. (1988) (10)
- The role of markers of bone turnover in the assessment of fracture risk in postmenopausal women. (1998) (10)
- Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis (2007) (10)
- Biochemical markers of bone turnover in osteoporosis. (1997) (9)
- The growth‐supportive effect of thrombospondin (TSP1) and the expression of TSP1 by human MG‐63 osteoblastic cells are both inhibited by dexamethasone (1993) (9)
- Circulating levels of osteonectin in normal subjects and patients with thrombocytopenia. (1990) (9)
- [Skeletal distribution and biological markers of Paget's disease]. (1989) (9)
- Cross-sectional and longitudinal assessment of pre- and postmenopausal bone loss with a portable forearm X-ray device: the Ofely study. (2000) (8)
- [Increase of vertebral bone density in heavy drinkers of mineral water with a high fluoride content]. (1989) (8)
- Strontium ranelate has a more positive influence than alendronate on distal tibia cortical and trabecular bone microstructure in women with postmenopausal osteoporosis (2009) (8)
- HRT in the prevention and treatment of osteoporosis. (1999) (8)
- Chapter 34. Biochemical Markers of Bone Turnover in Osteoporosis (2009) (8)
- of osteonecrosis of the jaw on osteoporosis management: executive summary of an ESCEO and Foundation for Research on Osteoporosis and other Bone Diseases Working Group Meeting (2007) (7)
- CHAPTER 63 – Biochemical Markers of Bone Turnover in Osteoporosis (2008) (7)
- [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents]. (1994) (7)
- Effects of 5 years of treatment with lasofoxifene on incidence of breast cancer in older women. (2009) (7)
- Prior clinical vertebral fractures are a particularly strong predictor of hip fracture: A meta-analysis (2006) (7)
- Insulin-like growth factor-II increases plasma osteocalcin concentration in newborn lambs. (1992) (7)
- Flutamide-Induced Methemoglobinemia (1991) (7)
- Biochemical markers of bone remodelling (1996) (6)
- Strontium ranelate : dose-dependent effects in postmenopausal osteoporosis : the STRATOS 2-year randomised trial (2001) (6)
- Is Nitric Oxide a Mediator of the Effects of Low-Intensity Electrical Stimulation on Bone in Ovariectomized Rats? (2010) (6)
- Maintaining the Trust of Physicians and the Public in the Medical Literature: Report of a Task Force on Scientific Publishing of Clinical Trials (2007) (6)
- Optimal Thresholds, Linear or Nonlinear Relationships of Fracture Risk Reduction With Therapy (2008) (6)
- How can we reduce the burden of osteoporosis? (1997) (6)
- New treatments for osteoporosis (1990) (6)
- Increased bone resorption and decreased bone formation in elderly women with hip fracture (1992) (6)
- Similar prevalence of vertebral fractures despite different approaches to define reference data. (2003) (5)
- [Assay of cross-linking molecules of collagen (pyridinolines) in the study of the degradation of bone tissue and articular cartilage]. (1993) (5)
- Vertebral fracture assessment using standard bone densitometry equipment predicts incident fractures in women (2008) (5)
- Early onset and sustained efficacy of raloxifene on incident vertebral fractures in postmenopausal women with ostoporosis : 4-year results from the MORE trial (2001) (5)
- [Biological markers of bone metabolism]. (1993) (5)
- Bone width is correlated positively with the upper to the lower segment ratio in elderly men--the MINOS study. (2007) (5)
- Poster 150: Effect of Once-Yearly Infusion of 5mg of Zoledronic Acid in Postmenopausal Women With Osteoporosis: The HORIZON-Pivotal Fracture Trial (2007) (5)
- [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)]. (1982) (5)
- Androgens increase osteoblast-stimulating activity of human breast cancer cells in vitro. (1986) (5)
- The Impact of Osteonecrosis of the Jaw on Osteoporosis Management : Executive Summary of a European Society on Clinical and Economic Aspects of Osteoporosis and Foundation for Research on Osteoporosis and other Bone Diseases Working Group Meeting (2007) (5)
- Bone histomorphometry and serum bone gla-protein in the diagnosis of primary hyperparathyroidism (1986) (5)
- [New bone imaging techniques in children with chronic kidney disease]. (2009) (5)
- Physiology of Bone Remodeling (1998) (5)
- [Measurement of lumbar bone mineral density by biphoton absorptiometry. Methodology. Reproductibility. Normal values]. (1987) (5)
- Review of ibandronate in the treatment of osteoporosis (2003) (5)
- Serum-free gamma carboxyglutamic acid (free Gla) is a poor biochemical marker of bone resorption in early postmenopausal women. (1991) (5)
- Prevention of non-steroidal anti-inflammatory drug (NSAID) induced gastropathy (1992) (4)
- Bone mass measurement: how, where, when and why? (1993) (4)
- Diagnostic procedures for osteoporosis in the elderly. (1995) (4)
- Rationale and design of the MOTION study (monthly oral therapy with ibandronate for osteoporosis intervention). (2005) (4)
- Biochemical Measurements of Bone Turnover (1989) (4)
- Use of dual-energy X-ray absorptiometry for the measurements of small quantities of mineral. (1997) (4)
- Standardization of bone marker nomenclature. (2001) (4)
- Raloxifene therapy for 3 years reduces the risk of incident vertebral fractures in postmenopausal women (1999) (4)
- The Short-Term Effects of Conjugated Estrogen on Bone Turnover in Older Women (1995) (4)
- Three-year follow-up of the use of transdermal 17beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women. (2001) (4)
- President Address (1898) (3)
- Erratum to “MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays” [Osteoarthritis Cartilage 15 (2007) 212–21] (2007) (3)
- COMPARAISON DE DEUX METHODES D'EVALUATION DE LA RATION CALCIQUE ALIMENTAIRE (1993) (3)
- The response of bone turnover markers to lasofoxifene: The PEARL trial (2009) (3)
- [Lumbar vertebrae mineral content in women. Normal values obtained using quantitative digital radiography]. (1989) (3)
- Methodological approach for the detection of both microdamage and fluorochrome labels in ewe bone and human trabecular bone (2011) (3)
- Proceedings of the Third International Conference on Osteoporosis held by the Health Council on Osteoporosis, Paris, France, October 20, 1995 (1996) (3)
- [Osteoporosis in the aged male]. (2002) (3)
- Use of alendronate after 5 years of treatment. (2007) (3)
- Discrepancy between bone resorption assayed by urinary excretion of pyridinoline crosslinks and of 3H-tetracycline in the rat (1992) (3)
- Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: The mobile study (2005) (3)
- Laboratory Assessment of Postmenopausal Osteoporosis (2006) (3)
- Monthly oral ibandronate is at least as effective as daily oral ibandronate: 1-year results from MOBILE (2005) (2)
- Oral monthly ibandronate in postmenopausal osteoporosis: Rationale and design of the mobile study (2003) (2)
- [Role of osteoclasts in the physiopathological mechanisms of malignant osteolysis]. (1993) (2)
- [Clinical usefulness of biochemical markers of bone remodeling in osteoporosis]. (1995) (2)
- Effects of raloxifene on bone mineral density and biochemical markers of bone turnover in postmenopausal women with osteoporosis : 4-year results from the MORE trial (2000) (2)
- Osteoporosis prevention clinical study program. (1996) (2)
- The use of biochemical markers of bone turnover in postmenopausal osteoporosis (2001) (2)
- Serum bone gla-protein compared to bone histomorphometry in hemodialyzed patients. (1986) (2)
- [Bone and hormones. Estrogens and antiestrogens: action on osteoporosis]. (1999) (2)
- [Comparison of two methods of evaluation of dietary calcium intake]. (1993) (2)
- Bisphosphonate Therapy and Hip Fractures Within the Risedronate and Alendronate (REAL) Cohort Study: Subgroup With Prior Fracture (2008) (2)
- DEGRADATION OF ALLOGRAFT BONE MECHANICAL AND BIOLOGICAL PROPERTIES BY GAMMA IRRADIATION CAN BE EXPLAINED BY ALTERATION TO THE COLLAGEN TRIPLE HELIX, RATHER THAN COLLAGEN CROSS-LINKS (2012) (2)
- Glucocorticoid-induced osteoblastic depression in ewes, a biochemical and histological study (1992) (2)
- Measuring Small Changes Versus Measurement Error (2007) (2)
- Risedronate for Paget's disease of bone. (1998) (2)
- Increased plasma free gamma carboxyglutamic acid levels during deep vein thrombosis and intravascular disseminated coagulation. (1994) (2)
- Nephronophthisis-like nephritis associated with fibrous dysplasia of bone (2008) (2)
- [The clinical use of biological markers of bone turnover in postmenopausal osteoporosis]. (2001) (2)
- Review of comparative effectiveness of treatments to prevent fractures. (2008) (2)
- Erratum to: Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy (2013) (2)
- Reduction in bone remodelling markers with monthly oral ibandronate (150 mg) and weekly alendronate (70 mg): results from the motion study (2008) (2)
- [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia]. (1984) (2)
- CHAPTER 37 – Laboratory Assessment of Postmenopausal Osteoporosis (2006) (2)
- Effects of denosumab and alendronate at the ultradistal radius in postmenopausal women with low bone mass (2009) (2)
- 11. Expression of an epitope recognised by BGP/ osteocalcin antisera in cultured fibroblast-like cells from human bone and skin (1989) (2)
- Osteosarcoma risk in rats using PTH 1-34 Response from Seeman and Delmas (2001) (1)
- European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Newsletter (2007) (1)
- Bone Mineral Measurement and Biochemical Markers of Bone Cell Function (1994) (1)
- [Permanent constriction of the jaws due to progressive ossifying myositis]. (1987) (1)
- Erratum: Risk factors for Colles' fracture in men and women: Results from the European Prospective Osteoporosis Study (Osteoporosis International (2003) 14 (213-218) DOI: org/10.1007/s00198-002-1364-1) (2004) (1)
- [GLA-protein of bone. Physiologic factor and new biological marker in bone pathology]. (1982) (1)
- EFFECT OF CO-MORBIDITIES ON FRACTURE RISK: FINDINGS FROM THE GLOW STUDY (2011) (1)
- Longitudinal study of bone mineral density (BMD) during 2.5 years of home parenteral nutrition (HPN). Influence of duration of nutrition and hormonal status (1992) (1)
- Body Composition (BC) Assessment by Dual Energy X Ray Absorptiometry (DXA)in Small subjects : Which software? 1563 (1998) (1)
- Comparison between 150 mg monthly and 5 mg daily risedronate in postmenopausal osteoporosis; Effects on bone quality and bone remodelling (2009) (1)
- Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate. (1984) (1)
- Pulsed estrogen therapy prevents late postmenopausal bone loss: a 2 year placebo-controlled study (2003) (1)
- Intermittent risedronate prevents bone loss in women with artificial menopause induced by chemotherapy of breast cancer (1995) (1)
- Immunoassay 25 25 2 Development and Clinical Application in Arthritis of a New Immunoassay for Serum Type IIA Procollagen NH 2 Propeptide (2019) (1)
- Recommendation for Bone Marker Nomenclature and Abbreviations (2001) (1)
- Value and limitations of cross-calibration in a multicenter study involving different DXA brands (1993) (1)
- [Treatment of postmenopausal osteoporosis]. (2005) (1)
- Pamidronate (Aredia) and zoledronate: update on clinical results. Introduction. (1996) (1)
- Iconography : A comparative review of the different techniques to assess hand bone damage in rheumatoid arthritis (2010) (1)
- Evaluation of the volumetric bone mineral density of the third lumbar vertebral body with a new x ray bone densitometer equipped with a rotating arm (1992) (1)
- Accelerated bone loss, but not low periosteal expansion, is associated with higher all-cause mortality in older men – prospective MINOS study (2010) (1)
- Noncarboxylated serum osteocalcin (ncOC) is a predictor of the risk of hip fracture in elderly women (1992) (1)
- [Osteoarticular complications of organ transplantations]. (1994) (1)
- Clodronate selectively inhibits the attachment of highly metastatic prostate carcinoma cells to bone extracellular matrix (1995) (1)
- Erratum: Early impairment of trabecular microarchitecture assessed with HR‐pQCT in patients with stage II‐IV chronic kidney disease (2012) (1)
- 11 Osteoporosis: outstanding issues (1997) (1)
- LONGITUDINAL STUDY OF WHOLE BODY BONE MINERAL CONTENT (wbBMC) IN INFANTS OF DIABETIC MOTHER (IDMs). † 1868 (1996) (1)
- [Bone imaging in patient with chronic kidney disease: a new tool for managing renal osteodystrophy?]. (2009) (1)
- [Bone and hormones. Effects of growth hormone on bone tissue in adults]. (1999) (1)
- Effects of denosumab and alendronate on skeletal microarchitecture (2009) (1)
- Effect of previous bisphosphonate use on response to zoledronic acid: Results from the HORIZON-PFT study (2008) (1)
- The pivotal role of cross-calibration and quality control in an international clinical trial of the strontium salt S-12911 involving multiple DXA brands (2006) (1)
- Denosumab and Alendronate Have Different Effects at the Ultradistal Radius in Postmenopausal Women With Low Bone Mass (2010) (1)
- The Use of Whole Body Dual X-Ray Absorptiometry (WB-DXA) for Measuring Very Small Amount Of Mineral. 145 (1996) (0)
- Long-term variability of markers (MK) of bone turnover: Implications for their diagnostic utility (2006) (0)
- Association between pre-existing microdamage, collagen cross-links, bone volume fraction and compressive mechanical properties of human vertebral trabecular bone (2009) (0)
- A method for the diagnosis of osteoarticular diseases or synovial (2000) (0)
- 16. Transfection of human osteoblast-like cells with SV-40 DNA (1991) (0)
- Do Low Bone Mineral Density and Lower Fracture Risk in Men with Metabolic Syndrome Have Different Determinants? - the MINOS Study (2009) (0)
- [Diphosphonates in the treatment of hypercalcemia]. (1984) (0)
- Infrared spectrum obtained from vertebral trabecular bone (man, 79 year-old). (2013) (0)
- Relationship between spine bone mineral density and vertebral fracture risk for antiresorptive agents using individual patient data vs. summary statistics (2002) (0)
- Association between bone stiffness and age. A micro-finite element analysis in women from the OFELY cohort (2011) (0)
- Prediction of fracture in the elderly (1996) (0)
- Intermittent intravenous ibandronate injections and daily oral ibandronate provide at least equivalent increases in bone mineral density: 1-year results from DIVA (2005) (0)
- Dissection of Radial DXA BMD Measurements Using High Resolution-Peripheral Quantitative Computed Tomography (HR-pQCT) Parameters (2008) (0)
- Osteoporosis International is growing and changing... (2006) (0)
- [A problem of public health neglected in spite of effective diagnostic and therapeutic means]. (2004) (0)
- Clinical synthesis meeting on osteoporosis (1999) (0)
- Ninth Bath Conference on Osteoporosis – abstracts (2003) (0)
- BONE TURNOVER AND MECHANICAL PROPERTIES FOLLOWING ONE YEAR TREATMENT WITH ANTI- REMODELING AGENTS IN SKELETALLY-MATURE BEAGLES (2006) (0)
- Assessment of 3D bone microarchitecture in femoral neck from postmenopausal women with hip fracture or hip osteoarthritis (2009) (0)
- Bone damage in primary hyperoxaluria type 1: a monocenter study using new bone imaging techniques (2008) (0)
- [Measurement of lumbar bone density by biphotonic absorptiometry. Contribution of a multidetector system]. (1990) (0)
- Bone quality in vertebral fracture: Microdamage, mineralisation and microarchitecture of the cortical shell in lumbar vertebrae (2009) (0)
- Prospective study of bone status under long term parenteral nutrition (LTPN) (1991) (0)
- Bone resorption measured on bone biopsies with an automatic analyser correlates with urinary excretion of pyridinoline crosslinks (1992) (0)
- Low Bone Turnover and Microdamage? How and Where to Assess It? (2008) (0)
- [Advances in the field of osteoporosis]. (2007) (0)
- 33rd EUROPEAN SYMPOSIUM ON CALCIFIED TISSUES (2006) (0)
- REVERSAL OF SEVERE HYPERPARATHYROIDISM IN HEMODIALYZED PATIENTS BY INTRAVENOUS ALFACALCIDOL AND CaCO3 AS SOLE PHOSPHATE BINDER ASSOCIATED WITH A LOW DIALYSATE CALCIUM (1991) (0)
- Once-monthly oral ibandronate a new bisphosphonate dosing concept (2004) (0)
- Procedures for diagnosing a synovial or osteoarticular pathology. (2000) (0)
- [Myelomatous bone. Histomorphometric study and therapeutic effects]. (1984) (0)
- [Fractures in children: epidemiological, diagnostic and therapeutic features]. (2004) (0)
- Methods and kits for the diagnosis or monitoring of a synovial or osteoarticular pathology comprising the use of a marker specific for the degradation of synovial tissue (1999) (0)
- Early (3-month) changes in serum osteocalcin and urinary C-telopeptide of type I collagen could be of interest to identify postmenopausal osteoporotic women with the highest risk to present new vertevral deformities (2001) (0)
- Tertatolol-induced lupus. (1988) (0)
- Oral monthly ibandronate: rationale and clinical potential in postmenopausal osteoporosis (2003) (0)
- [Clinical results of selective estrogen receptor modulators (SERM)]. (2000) (0)
- [The menopause and bone metabolism]. (1985) (0)
- In memoriam: Pierre Delmas (2008) (0)
- The monthly oral therapy with ibandronate for osteoporosis intervention (motion) study: Rationale and design (2006) (0)
- O5. Sex variation in vertebral deformity indices (1994) (0)
- [Comparative study of serum osteocalcin and of the histomorphometric evaluation of iliac biopsy in postmenopausal osteoporosis]. (1984) (0)
- [Menopause and bone metabolism]. (1984) (0)
- A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data (2012) (0)
- Genant Recognizing and reporting osteoporotic vertebral fractures (2005) (0)
- Oral communications abstracts (2007) (0)
- Significant reduction in vertebral fracture risk: Evidence for the efficacy of daily and intermittent ibandronate from a large phase III study (2003) (0)
- Radiographic knee osteoarthritis presence and severity is associated with the urinary biochemical markers CTX-II and glucosyl-galactosyl-pyridinoline (2005) (0)
- A specific two-site radioimmunoassay for intact human osteocalcin (1992) (0)
- Measuring small changes versus measurement error - Reply (2008) (0)
- [Prevention of osteoporosis]. (1987) (0)
- LS1 Setting Goals for Enhancement of Quality of Life After Menopause(ISPOG2007) (2007) (0)
- Bone status at the beginning of home parenteral nutrition (HPN) (1992) (0)
- 108 PATIENTS WITH RHEUMATOID ARTHRITIS HAVE AN ALTERED AGGRECAN PROFILE IN SERUM (2007) (0)
- HIGH PREVALENCE OF VITAMIN D INADEQUACY AMONG COMMUNITY-DWELLING POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: 27 (2006) (0)
- Bone gla: Protein in blood derived directly from human bone tissue (1989) (0)
- [Evaluation of vertebral fractures with dual energy absorptiometry: is it an alternative to conventional radiography?]. (2004) (0)
- Recommendationsfortheregistrationofagents forpreventionandtreatmentofglucocorticoid-induced osteoporosis:anupdatefromtheGroupfortheRespect ofEthicsandExcellenceinScience (2008) (0)
- Osteoporosis is not a controversial condition (2017) (0)
- Effect of bisphosphonate treatment on the urinary excretion of C-telopeptide degradation products of type I collagen measured in the crosslaps⊥M ELISA (1995) (0)
- [Osteoporosis. Epidemiology, etiology, diagnosis, prevention]. (1997) (0)
- Changes of body composition (fat and lean mass) with age and menopause (MP). The ofely cohort (2006) (0)
- Proceedings of European congress on osteoporosis, September 11-15 1998, Berlin (1999) (0)
- 109 IDENTIFICATION OF AGGRECANASES-MEDIATED AGGRECAN FRAGMENT CIRCULATING IN HUMAN PLASMA FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS (RA) (2008) (0)
- MARKERS OF BONE TURNOVER IN PATIENTS WITH CANCER (2001) (0)
- Measurement of bone resorption in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen (2006) (0)
- [Selective modulators of estrogen receptors]. (2000) (0)
- National Osteoporosis Society: Abstracts of 11th Conference on Osteoporosis, 25--28 June 2006, Harrogate, UK (2006) (0)
- Effects of SERMs on Bone in Clinical Studies (2002) (0)
- [Therapeutic strategies for osteoporosis]. (2000) (0)
- Misleading clavicular osteolytic lesion revealing fibrous dysplasia. (2006) (0)
- Strontium ranelate decreases the risk of hip fracture over 3 and 5 years in post menopausal women at high risk (2008) (0)
- Increase in femoral neck bone mineral density is associated with decrease in hip fracture incidence during treatment with strontium ranelate (2006) (0)
- Biochemical markers of bone turnover: Technical aspects and clinical application (2006) (0)
- Symposia Abstracts (2017) (0)
- [Treatment of Paget's disease of bone]. (1980) (0)
- Estrogen and estrogen-like substances in women's health : the year 2000 : Fourth International Symposium organized by the Health Council on Osteoporosis, Paris, October 25, 1996 (1997) (0)
- [Pathogenesis of postmenopausal bone loss. Therapeutic implications]. (2000) (0)
- The Management of Postmenopausal Osteoporosis: A Position Paper of the World Health Origination Collaborating Center on Public Health Aspects of Rheumatic Diseases (2005) (0)
- [Biphosphonates in the treatment of osteolytic metastasis. Essential actions on hypercalcemia and important on lytic lesions]. (1993) (0)
- Epitope mapping of two monoclonal antibodies to the central portion of human osteonectin (1991) (0)
- Interest of four biochemical markers of bone turnover in prediction of baseline and long-term (changes) of bone mineral density in postmenopausal osteoporotic women (2001) (0)
- Osteoporosis: outstanding issues. (1997) (0)
- Hypovitaminosis D is the main determinant of secondary hyperparathyroidism which contributes to bone fragility in elderly women with hip fractures and other non vertebral fractures (1992) (0)
- Significant bone loss at the hip in women under hormone replacement therapy (HRT) for more than 4 years. The ofely prospective study (2006) (0)
- Relations between increase in femoral neck bone mineral density and decrease in hip fracture incidence during treatment with strontium ranelate (2006) (0)
- Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with both presence and severity of radiographic knee osteoarthritis (2004) (0)
- [Physiopathology of malignant osteolysis]. (1990) (0)
- Assessment of serum bone alkaline phosphatase activity with a new elisa using a specific monoclonal antibody (2006) (0)
- Bone mineral density and biochemical marker response rates in postmenopausal women after treatment with zoledronic acid (2008) (0)
- Osteoporose-Update 1/2007 (2007) (0)
- Lower cortical thickness and density in older men with low bioavailable estradiol level - The strambo study (2010) (0)
- Finite Element Analyses Based on In Vivo HR-pQCT Images of the Distal Radius Improves Wrist Fracture Discrimination Compared to BMD (2002) (0)
- In memoriam: Pierre Delmas (2008) (0)
- Effect of hormonal replacement therapy withdrawal on bone mass and bone turnover The OFELY study (2000) (0)
- Chairman's introduction (1993) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Pierre Dominique Delmas?
Pierre Dominique Delmas is affiliated with the following schools:
